-------- Original Version -----------
Press Release: Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews-------- English Version ------------
Press Release: Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews-------- Link if available ----------